Warning letter
Pharmacy Associates Incorporated: warning letter of Feb 4, 2000
FDA warning letter UCM068092 · Baltimore District Office
Key facts
| Reference number | UCM068092 |
|---|---|
| Company | Pharmacy Associates Incorporated |
| Subject | Medical Gas Manufacturing Facility |
| Issue date | Feb 4, 2000 |
| Posted date | Feb 4, 2000 |
| Issuing office | Baltimore District Office |
| Product type | Drugs |
| CFR sections cited | 211 |
| Country | 3 |
| Inspection city | Parkersburg |
| Inspection ZIP | 26101 |
| Inspection start date | Jan 20, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: